Psychometric Performance of the Incontinence Quality-of-Life Questionnaire Among Patients With Overactive Bladder and Urinary Incontinence

被引:26
作者
Patrick, Donald L. [1 ]
Khalaf, Kristin M. [2 ]
Dmochowski, Roger [3 ]
Kowalski, Jonathan W. [2 ]
Globe, Denise R. [2 ]
机构
[1] Univ Washington, Sch Publ Hlth, Seattle, WA 98195 USA
[2] Allergan Pharmaceut Inc, Urol Therapeut Area, Irvine, CA USA
[3] Vanderbilt Univ, Med Ctr, Dept Urol, Nashville, TN USA
关键词
I-QOL; onabotulinumtoxinA; overactive bladder; psychometrics; quality of life; urinary incontinence; TRACT SYMPTOMS; PLACEBO; DULOXETINE; WOMEN; SEVERITY; EFFICACY; SAFETY;
D O I
10.1016/j.clinthera.2013.04.013
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: The Incontinence Quality-of-Life Instrument (I-QOL) is a condition-specific questionnaire that assesses the health-related QOL impact of urinary incontinence, but it has not been validated in patients with overactive bladder (OAB) who have been inadequately managed by anticholinergic therapy. Objective: This study assessed the reliability and validity of the I-QOL among patients with OAB with urinary incontinence. Methods: I-QOL scores were analyzed from a Phase II study that compared the efficacy and tolerability of onabotulinumtoxinA and placebo. Conceptual framework was confirmed via confirmatory factor analysis. Reliability was assessed using Cronbach's alpha and intraclass correlation coefficients (ICCs). Validity was tested by comparing I-QOL scores to tertiles of urinary symptom severity. Effect size statistics estimated the ability of the I-QOL to detect change. Responder analysis with cumulative distribution function was plotted to show differentiation between treatment groups with respect to I-QOL scores. Results: Comparative fit indices ranged from 0.87 to 0.99 on the confirmatory factor analysis. I-QOL scores showed high internal consistency (0.86 <= Cronbach's alpha <= 0.93), good test-retest reliability (0.68 <= ICC <= 0.84), and good differentiation between tertiles of increasing urinary symptom severity (all, P <= 0.002). Significant differences in I-QOL change scores were noted between responders and nonresponders across all responder definitions (all, P < 0.001) and corresponded with large effect sizes among responders to treatment (1.34 <= effect size <= 2.82). Conclusion: This study demonstrated that OAB with urinary incontinence affects health-related QOL and that the I-QOL reliably and validly measures these impacts. (C) 2013 Elsevier HS Journals, Inc. All rights reserved.
引用
收藏
页码:836 / 845
页数:10
相关论文
共 30 条
  • [1] Aaronson N, 2002, QUAL LIFE RES, V11, P193
  • [2] Describing bladder storage function: Overactive bladder syndrome and detrusor overactivity
    Abrams, P
    [J]. UROLOGY, 2003, 62 (5B) : 28 - 37
  • [3] Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome
    Abrams, Paul
    Cardozo, Linda
    Chapple, Christopher
    Serdarevic, Dzelal
    Hargreaves, Katherine
    Khullar, Vikram
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2006, 13 (06) : 692 - 698
  • [4] RELATIONSHIP OF SYMPTOMS OF PROSTATISM TO COMMONLY USED PHYSIOLOGICAL AND ANATOMICAL MEASURES OF THE SEVERITY OF BENIGN PROSTATIC HYPERPLASIA
    BARRY, MJ
    COCKETT, ATK
    HOLTGREWE, HL
    MCCONNELL, JD
    SIHELNIK, SA
    WINFIELD, HN
    [J]. JOURNAL OF UROLOGY, 1993, 150 (02) : 351 - 358
  • [5] BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588
  • [6] BRENNER MH, 1995, MED CARE, V33, pAS236
  • [7] Quality of life of women with urinary incontinence: Cross-cultural performance of 15 language versions of the I-QOL
    Bushnell, DM
    Martin, ML
    Summers, KH
    Svihra, J
    Lionis, C
    Patrick, DL
    [J]. QUALITY OF LIFE RESEARCH, 2005, 14 (08) : 1901 - 1913
  • [8] Treatment success for overactive bladder with urinary urge incontinence refractory to oral antimuscarinics: A review of published evidence
    Campbell J.D.
    Gries K.S.
    Watanabe J.H.
    Ravelo A.
    Dmochowski R.R.
    Sullivan S.D.
    [J]. BMC Urology, 9 (1)
  • [9] Development and validation of patient-reported outcomes measures for overactive bladder: A review of concepts
    Coyne, Karin S.
    Tubaro, Andrea
    Brubaker, Linda
    Bavendam, Tamara
    [J]. UROLOGY, 2006, 68 (2A) : 9 - 16
  • [10] de la Rosette JJMCH, 1998, NEUROUROL URODYNAM, V17, P99, DOI 10.1002/(SICI)1520-6777(1998)17:2<99::AID-NAU3>3.0.CO